|
|
Boston Scientific Corporation (BSX) |
|
|
|
| |
BSX's Operating Income Growth by Quarter and Year
Boston Scientific's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| BSX Operating Income (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
402.00
|
180.00
|
50.00
|
| III Quarter |
September |
693.00
|
358.00
|
387.00
|
-205.00
|
| II Quarter |
June |
514.00
|
423.00
|
262.00
|
-71.00
|
| I Quarter |
March |
552.00
|
466.00
|
370.00
|
146.00
|
| FY |
|
1,759.00
|
1,649.00
|
1,199.00
|
-80.00
|
| BSX Operating Income third quarter 2023 Y/Y Growth Comment |
Boston Scientific Corporation achieved in the third quarter 2023, above Company average Operating Income rise of 93.58% year on year, to $ 693.00 millions.
Looking into third quarter 2023 results within Medical Equipment & Supplies industry 18 other companies have achieved higher Operating Income growth. While Boston Scientific Corporation' s Operating Income jump of 93.58% ranks overall at the positon no. 768 in the third quarter 2023.
Explain Operating Income growth
|
| BSX Operating Income ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
123.33 % |
260 % |
-76.19 % |
| III Quarter |
September |
93.58 % |
-7.49 % |
- |
- |
| II Quarter |
June |
21.51 % |
61.45 % |
- |
- |
| I Quarter |
March |
18.45 % |
25.95 % |
153.42 % |
-54.23 % |
| FY |
|
- |
37.53 % |
- |
- |
BSX Operating Income (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
12.29 % |
-53.49 % |
- |
| III Quarter |
September |
34.82 % |
-15.37 % |
47.71 % |
- |
| II Quarter |
June |
-6.88 % |
-9.23 % |
-29.19 % |
- |
| I Quarter |
March |
37.31 % |
158.89 % |
640 % |
-30.48 % |
| FY (Year on Year) |
|
- |
37.53 % |
- |
- |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 2972.22 % |
-16.79 % |
-844.17 % |
| (Sep 30 2017) |
|
(March 31, 2009) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 2972.22 % |
-16.79 % |
-844.17 % |
| (Sep 30 2017) |
|
(March 31, 2009) |
|
| Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Boston Scientific's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 2400 % |
79.94 % |
-90.76 % |
| (June 30, 2009) |
|
|
| BSX's III. Quarter Q/Q Operating Income Comment |
Boston Scientific Corporation achieved in the III. Quarter 2023 below company average Operating Income jump of 34.82% quarter on quarter, to $ 693.00 millions.
III. Quarter 2023 Boston Scientific's performance appear to be a mixed bag, albeit lower than the average, yet it presents absolute recovery compare to the -15.37% in the same quarter a year ago Pedro Barbosa, Healthcare sector expert based in Porto wrote.
Within Medical Equipment & Supplies industry 10 other companies have achieved higher Operating Income quarter on quarter growth. While Boston Scientific's Operating Income growth quarter on quarter, overall rank is 262. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 2400 % |
79.94 % |
-90.76 % |
| (June 30, 2009) |
|
|
| BSX's III. Quarter Q/Q Operating Income Comment |
Boston Scientific Corporation achieved in the III. Quarter 2023 below company average Operating Income jump of 34.82% quarter on quarter, to $ 693.00 millions.
III. Quarter 2023 performance seem to be contradictory, albeit below the regular, yet it demonstrates a quite improvement relative to the -15.37% in the same quarter a year ago Pedro Barbosa, Healthcare sector expert based in Porto said.
Within Medical Equipment & Supplies industry 10 other companies have achieved higher Operating Income quarter on quarter growth. While Boston Scientific's Operating Income growth quarter on quarter, overall rank is 262. |
|
Boston Scientific's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Sep 30 2023) |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
| Cumulative Operating Income 12 Months Ending |
$ 2,161.00 |
$ 1,826.00 |
$ 1,735.00 |
$ 1,649.00 |
$ 1,427.00 |
| Y / Y Operating Income Growth (TTM) |
51.44 % |
25.41 % |
33.98 % |
37.53 % |
33.49 % |
| Year on Year Operating Income Growth Overall
Ranking |
# 329 |
# 56 |
# 22 |
# 18 |
# 400 |
| Seqeuential Operating Income Change (TTM) |
18.35 % |
5.24 % |
5.22 % |
15.56 % |
-1.99 % |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 768 |
# 531 |
# 1037 |
# 762 |
# 936 |
| Cumulative Operating Income growth
Comment |
Boston Scientific saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 51.44% year on year, to $ 2,161 millions if the fiscal year would have ended in Sep 30 2023.
Boston Scientific's trailing twelve months Operating Income growth was higher than company's average -16.79% and higher than 25.41% growth in Jun 30 2023.
But from the previous reporting period increase was slower at 18.35 % from $1826 millions achieved in the period from Jun 30 2023 to Sep 30 2022 Pedro Barbosa continued.
Yet it was evidence of convincing trend, while the average sequential Operating Income growth is at -16.79%.
The growth is even higher sequentially clinched at 18.35 % increase from $1826 millions in twelve months ending a quarter before.
Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 56 to 329. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
2972.22 % |
-16.79 % |
-844.17 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
2972.22 % |
-16.79 % |
-844.17 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 19 |
| Sector |
# 47 |
| S&P 500 |
# 768 |
|
| Cumulative Operating Income growth
Comment |
Boston Scientific saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 51.44% year on year, to $ 2,161 millions if the fiscal year would have ended in Sep 30 2023.
Boston Scientific's trailing twelve months Operating Income growth was higher than company's average -16.79% and higher than 25.41% growth in Jun 30 2023.
But from the previous reporting period increase was beneth at 18.35 % from $1826 millions reported in twelve months ending a quarter Jun 30 2023.
Yet this was evidence of positive momentum, as the usual Q/Q TTM advancement stands at -16.79%.
The momentum is even higher sequentially showed at 18.35 % rise from $1826 millions in the period from Jun 30 2023 to Sep 30 2022.
Among companies within the Healthcare sector 18 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 56 to 329. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
2972.22 % |
-16.79 % |
-844.17 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
2972.22 % |
-16.79 % |
-844.17 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 19 |
| Sector |
# 47 |
| S&P 500 |
# 768 |
|
132.33%